Interestingly, our findings aligned with one of our previous studies showing that activation of the farnesoid X–activated receptor stimulated bile secretion and prevented the formation of NEC (data submitted elsewhere), as reflected in the decreased levels of SLC12A2. The gene discussed is SLC12A2; the disease is necrotizing enterocolitis.